Chiodo, Tiziana,Hafner, Andreas,Hintermann, Tobias,Salvador, Beate,Szelagiewicz, Martin,Blatter, Fritz,Rodel, Eva,Vossen, Marcus
申请号：
AU2013333953
公开号：
AU2013333953A1
申请日:
2013.10.16
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial.
